Navigation Links
Generic Biologics – U.S Panel Hearing Draws Mixed Response

There are varied reactions to the U.S panel hearing that cheaper versions of biologic drugs// can be manufactured.

The Senate Health, Education, Labor and Pensions Committee is considering legislation that would give the Food and Drug Administration legal authority to approve alternative versions of expensive biologic drugs after patents expire.

Yet it has drawn both brickbats and accolades from various sections.

Says Jay Siegel, head of research for Johnson & Johnson's biotechnology business: ' You just can't take a molecule that you don't know what it is and market it to the people. It's too risky.'

He opines that rival products also known as follow-on biologics should be put up for extensive clinic studies and post approval studies before approval.

Nicolas Rossignol, who oversees implementation of the European Commission’s legislation on biosimilars, told the panel some biologics like insulin and human growth hormones are fairly simple to produce as generics, but that other more complex biologic drugs cannot be reliably duplicated. In general, European regulators advise caution.

Ajaz Hussain, who oversees biological drugs for Novartis AG's generics unit Sandoz,in contrast says science reveals that follow-on biologics can treat the same conditions as their more expensive counterparts.

'FDA already has the expertise' to review them, he told the panel. 'What you need to do is to empower them to act.'

His feelings are echoed by AARP (representing millions of American seniors, and America's Health Insurance Plans) President Erik Olsen:'A therapy is only helpful to the patient who has access to it.

'Biologics hold great promise for treating serious diseases such as cancer, multiple sclerosis, anemia and rheumatoid arthritis, but when some treatments cost thousands of dollars per dose, many patients cannot afford to fill their prescriptions.

'Science has progressed to t he point where it is possible to create generic biologics and to do so safely. All FDA lacks is the authority to approve these therapies,' he added.

The repercussions of the decision will extend to other areas.

Employers and insurers see this development as a means to curb skyrocketing health care cost.

In addition to private health providers, the U.S. government, which runs the Medicare and Medicaid insurance programs for the elderly, disabled and poor, also stands to save millions of dollars.

While different politic parties support diverse views, Sen. Mike Enzi, Wyoming Republican advises caution, ' Any time we start legislating on complex scientific issues and don't know all the facts, we risk endangering lives.'
ANN
'"/>




Related medicine news :

1. Generic drug costs remain shackled
2. FDA Approves Indian Generic Drug For AIDS Treatment
3. Proper Validation of Generic Drugs Could Save Millions of AIDS Patients
4. AIDS Generic Drugs Approved by FDA for Sale in US
5. HIV Mortality declining in India due to Generic Antiretroviral therapy drugs
6. Generic Drugs Usage In US Can Save $20 Billion – Express Script Surve
7. Generic Products Compete With GlaxoSmithKline
8. ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin
9. Ranbaxy Expands By Acquiring A Generic Company In Belgium
10. First Generic Version of Lexapro permitted by US
11. Dr Reddys Launches Generic Version Of Mercks Proscar Tablets
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/17/2019)... , ... September 17, 2019 , ... ... is pleased to announce the release of the third edition of The Gift ... easy-to-read guide for patients, caregivers and families to navigate the clinical research process. ...
(Date:9/17/2019)... ... September 17, 2019 , ... ... Open House day on Pacifica's Lambert Campus, 249 Lambert Road, Carpinteria, CA. ... the Humanities, Clinical Psychology, Counseling Psychology, and Mythological Studies. Program Faculty will ...
(Date:9/14/2019)... ... ... GreenTheVoteOk , one of the most reliable online resource providers on ... relevant and important developments in the fast-changing world of legalized CBD. , With ... the world suffering from different difficult-to-treat ailments, people need to identify brands that offer ...
(Date:9/11/2019)... ... 2019 , ... “Heart Seizures”: a useful source of knowledge that tells about ... to prevent anyone from having it and to help those who are suffering with ... was diagnosed with coronary artery disease. Predicted to experience another probable heart attack six ...
(Date:9/11/2019)... ... , ... A September 2 article on CBS News details a ... likely to suffer heart attacks, strokes, kidney failure, and heart disease versus a control ... surgery specialists Dr. Feiz and Associates says the study adds further evidence to an ...
Breaking Medicine News(10 mins):
(Date:9/17/2019)... ... September 17, 2019 , ... For the 6th year in a row, Mental ... ranks all 50 states and the District of Columbia based on several mental health and ... The report also takes a look back on the trends of the last 6 years ...
(Date:9/17/2019)... ... ... Drs. Nickelice Brand and Chris Williams restore smiles of Ocala, FL patients ... implants are a nearly permanent, comfortable and efficient way for patients to replace their ... when placed by highly trained professionals such as Drs. Brand and Williams, providing patients ...
(Date:9/17/2019)... ... , ... Embr Labs , the breakthrough thermal technology company and creator ... DigiTx Partners, with participation from Safar Partners, Joyance Partners , Bose ... company’s footprint in wellness and digital therapeutics, accelerate development for the next generation of ...
Breaking Medicine Technology: